Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein-Barr Virus-Associated Gastric Cancer.
Frontiers In Oncology
Lv, Wanrui W; Cheng, Ke K; Li, Xiaofen X; Feng, Lusi L; Li, Hancong H; Li, Jia J; Chang, Chen C; Cao, Dan D